Drug Importation Often Driven By Personal, Not Pricing, Concerns, FDA Finds
Executive Summary
Prescription-free access to pharmaceuticals, as opposed to saving money, is the motivation for a large number of Americans who purchase drugs online, according to FDA Acting Deputy Commissioner-Policy Randall Lutter
You may also be interested in...
Rx Importation Sinks In Senate, But Leaves Anticounterfeiting Regs In Its Wake
Although the drug importation provisions included in the Senate's version of the FDA Revitalization Act are not expected to create a cross-border trading system, their anticounterfeiting language could still have a significant impact on industry
Reimportation Bill From Dorgan/Snowe Includes User Fees To Fund Oversight
A reimportation bill reintroduced by Sens. Byron Dorgan (D-N.D.) and Olympia Snowe (R-Maine) includes user fees for importers and foreign exporters to fund FDA's safety oversight
Rx Misbranding Penalties Should Be Stronger To Stop Counterfeiting, FDA Says
Industry also seems supportive of the idea, while Pew touts the power of the power of track-and-trace as a deterrent.